Long-term Prognosis of patients with neovascular age-related macular degeneration

Long-term Prognosis of patients with neovascular age-related macular degeneration - Long-term Prognosis of patients with neovascular age-related macular degeneration

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000046415

Enrollment

500

Registered

2021-12-20

Start date

2020-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neovascular age-related macular degeneration

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients who were diagnosed with Neovascular age-related macular degeneration at Nagoya City University Hospital since April 2005 underwent intravitreal anti-vascular endothelial growth factor injection or photodynamic therapy, and could be followed up for at least 1 year were included.

Exclusion criteria

Exclusion criteria: The patients without the necessary data or eyes with history of other vitreoretinal diseases such as retinal detachment, diabetic retinopathy, retinal vein occlusion, and uveitis were excluded.

Design outcomes

Primary

Measure	Time frame
Best-corrected visual acuity	—

Countries

Japan

Contacts

Public ContactAki Kato

Nagoya City University Graduate School of Medical Sciences Department of Ophthalmology and Visual Science

akikato@med.nagoya-cu.ac.jp+81-52-8538251

Outcome results